Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients

Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients

Bibliographic Details
Main Authors: Dominika Wcisło-Dziadecka, Beniamin Grabarek, Celina Kruszniewska-Rajs, Andrzej Swinarew, Krzysztof Jasik, Beata Rozwadowska, Agata Krawczyk
Format: Article
Language:English
Published: Termedia Publishing House 2020-11-01
Series:Advances in Dermatology and Allergology
Subjects:
tumor necrosis factor a
treatment personalisation
mirna
anti-tnf therapy
psoriasis.
Online Access:https://www.termedia.pl/Analysis-of-molecular-and-clinical-parameters-of-4-year-r-nadalimumab-therapy-in-psoriatic-patients,7,42294,1,1.html
id doaj-859cc623fbaf428c8cb979bb20e8c1ec
record_format Article
spelling doaj-859cc623fbaf428c8cb979bb20e8c1ec2021-10-06T07:49:11ZengTermedia Publishing HouseAdvances in Dermatology and Allergology1642-395X2299-00462020-11-0137573674510.5114/ada.2020.10048442294Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patientsDominika Wcisło-DziadeckaBeniamin GrabarekCelina Kruszniewska-RajsAndrzej SwinarewKrzysztof JasikBeata RozwadowskaAgata Krawczykhttps://www.termedia.pl/Analysis-of-molecular-and-clinical-parameters-of-4-year-r-nadalimumab-therapy-in-psoriatic-patients,7,42294,1,1.htmltumor necrosis factor a treatment personalisation mirna anti-tnf therapy psoriasis.
collection DOAJ
language English
format Article
sources DOAJ
author Dominika Wcisło-Dziadecka
Beniamin Grabarek
Celina Kruszniewska-Rajs
Andrzej Swinarew
Krzysztof Jasik
Beata Rozwadowska
Agata Krawczyk
spellingShingle Dominika Wcisło-Dziadecka
Beniamin Grabarek
Celina Kruszniewska-Rajs
Andrzej Swinarew
Krzysztof Jasik
Beata Rozwadowska
Agata Krawczyk
Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
Advances in Dermatology and Allergology
tumor necrosis factor a
treatment personalisation
mirna
anti-tnf therapy
psoriasis.
author_facet Dominika Wcisło-Dziadecka
Beniamin Grabarek
Celina Kruszniewska-Rajs
Andrzej Swinarew
Krzysztof Jasik
Beata Rozwadowska
Agata Krawczyk
author_sort Dominika Wcisło-Dziadecka
title Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
title_short Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
title_full Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
title_fullStr Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
title_full_unstemmed Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
title_sort analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
publisher Termedia Publishing House
series Advances in Dermatology and Allergology
issn 1642-395X
2299-0046
publishDate 2020-11-01
topic tumor necrosis factor a
treatment personalisation
mirna
anti-tnf therapy
psoriasis.
url https://www.termedia.pl/Analysis-of-molecular-and-clinical-parameters-of-4-year-r-nadalimumab-therapy-in-psoriatic-patients,7,42294,1,1.html
work_keys_str_mv AT dominikawcisłodziadecka analysisofmolecularandclinicalparametersof4yearadalimumabtherapyinpsoriaticpatients
AT beniamingrabarek analysisofmolecularandclinicalparametersof4yearadalimumabtherapyinpsoriaticpatients
AT celinakruszniewskarajs analysisofmolecularandclinicalparametersof4yearadalimumabtherapyinpsoriaticpatients
AT andrzejswinarew analysisofmolecularandclinicalparametersof4yearadalimumabtherapyinpsoriaticpatients
AT krzysztofjasik analysisofmolecularandclinicalparametersof4yearadalimumabtherapyinpsoriaticpatients
AT beatarozwadowska analysisofmolecularandclinicalparametersof4yearadalimumabtherapyinpsoriaticpatients
AT agatakrawczyk analysisofmolecularandclinicalparametersof4yearadalimumabtherapyinpsoriaticpatients
_version_ 1716841165220741120

Similar Items